First-of-its-kind Edwards SAPIEN M3 transcatheter mitral valve system secures FDA approval for transseptal mitral ...

Click here for a full review of mitral regurgitation. Below is a brief summary. Mitral regurgitation is the abnormal backward flow of blood from the left ventricle (LV) to the left atrium (LA) due to ...

How to navigate the likelihood ratios for mitral regurgitation presented by the physical exam, particularly auscultation, are the focus of this episode of AP Cardiology with host Andrew Perry, MD, ...

Edwards Lifesciences EW announced that the FDA approved its SAPIEN M3 transcatheter mitral valve replacement system, making ...

The SAPIEN M3 system received CE Mark in April 2025, making it the world’s first approved transfemoral transcatheter mitral ...

A keyhole surgery procedure for mitral valve disease has been rolled out across the NHS this week after a decade-long delay due to funding struggles. The procedure, trans-catheter edge-to-edge repair ...

SAN FRANCISCO — A novel transcatheter-based treatment appears to be safe and efficacious in patients with severe tricuspid regurgitation, according to results presented at the annual TCT Scientific ...

Serotonin can impact the mitral valve of the heart and potentially accelerate a cardiac condition known as degenerative mitral regurgitation, according to a new study led by researchers at Columbia ...

The mitral valve clip, which is marketed in the U.S. as the MitraClip, is a minimally invasive, non-surgical alternative used to repair a damaged mitral heart valve. The mitral valve clip procedure ...

Edwards Lifesciences announced today that its Sapien M3 mitral valve replacement system received FDA approval for mitral ...

The Sapien M3 device is the first approved mitral regurgitation treatment to use a transseptal approach, Edwards said.